|
Synonyms: Azasan® | BW-57-322 | Imuran® | Jayempi®
azathioprine is an approved drug (FDA (1968), EMA (2021))
Compound class:
Synthetic organic
Comment: Azathioprine is an immunosuppressive antimetabolite. The active drug is believed to be mercaptopurine.
Marketed formulations may contain azathioprine sodium (PubChem CID 23678403). |
|
|||||||||||||||||||||||||||||||||||
| Immunopharmacology Disease | |||
| Disease | X-Refs | Comment | References |
| Systemic lupus erythematosus |
Disease Ontology:
DOID:9074 OMIM: 152700 Orphanet: ORPHA536 |
Approved drug for SLE. | |
| Rheumatoid arthritis |
Disease Ontology:
DOID:7148 OMIM: 180300 |
Approved drug for RA. | |
| Crohn's disease |
Disease Ontology:
DOID:8778 OMIM: 266600 Orphanet: ORPHA206 |
Approved drug for CD. | |
| Ulcerative colitis |
Disease Ontology:
DOID:8577 OMIM: 266600 Orphanet: ORPHA771 |
Approved drug for UC. | |
| Immunopaedia Case Studies Links |
| Fireworks of autoimmunity from birth |
| My eyes cross at twilight |